These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15843747)

  • 1. [Hepatocellular carcinoma in Korea: introduction and overview].
    Park JW
    Korean J Gastroenterol; 2005 Apr; 45(4):217-26. PubMed ID: 15843747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Practice guideline for diagnosis and treatment of hepatocellular carcinoma].
    Park JW;
    Korean J Hepatol; 2004 Jun; 10(2):88-98. PubMed ID: 15218342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of hepatocellular carcinoma in Japan and Korea. A review.
    Kim SR; Kudo M; Hino O; Han KH; Chung YH; Lee HS;
    Oncology; 2008; 75 Suppl 1():13-6. PubMed ID: 19092267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: promoting the early detection of hepatocellular carcinoma in China.
    Song P; Feng X; Zhang K; Song T; Ma K; Kokudo N; Dong J; Yao L; Tang W
    Biosci Trends; 2013 Feb; 7(1):1-6. PubMed ID: 23524887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of hepatitis C virus infection in Korea.
    Suh DJ; Jeong SH
    Intervirology; 2006; 49(1-2):70-5. PubMed ID: 16166792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of liver diseases in Korea: hepatocellular carcinoma.
    Song IH; Kim KS
    Korean J Hepatol; 2009 Dec; 15 Suppl 6():S50-9. PubMed ID: 20037280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort.
    Sinn DH; Gwak GY; Cho J; Paik SW; Yoo BC
    PLoS One; 2014; 9(11):e112184. PubMed ID: 25372403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients.
    Utsunomiya T; Shimada M; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Takayama T; Kokudo N;
    Ann Surg; 2015 Mar; 261(3):513-20. PubMed ID: 25072437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral hepatitis B and hepatocellular carcinoma.
    Michielsen P; Ho E
    Acta Gastroenterol Belg; 2011 Mar; 74(1):4-8. PubMed ID: 21563647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral hepatitis and liver cancer in Korea: an epidemiological perspective.
    Yeo Y; Gwack J; Kang S; Koo B; Jung SJ; Dhamala P; Ko KP; Lim YK; Yoo KY
    Asian Pac J Cancer Prev; 2013; 14(11):6227-31. PubMed ID: 24377509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is the prevalence of cryptogenic hepatocellular carcinoma increasing in Korea?].
    Oh KC; Park SH; Park JC; Jin DK; Park CS; Kim KO; Jang HJ; Lee JY; Park CH; Han TH; Yoo KS; Kim JH; Kim DJ; Lee MS; Park CK
    Korean J Gastroenterol; 2005 Jan; 45(1):45-51. PubMed ID: 15665567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma: an Asian perspective.
    Teo EK; Fock KM
    Dig Dis; 2001; 19(4):263-8. PubMed ID: 11935085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan.
    Chen CT; Chen JY; Wang JH; Chang KC; Tseng PL; Kee KM; Chen PF; Tsai LS; Chen SC; Lin SC; Lu SN
    Kaohsiung J Med Sci; 2013 Aug; 29(8):451-9. PubMed ID: 23906236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area.
    Cho EJ; Kwack MS; Jang ES; You SJ; Lee JH; Kim YJ; Yoon JH; Lee HS
    Digestion; 2011; 84 Suppl 1():17-22. PubMed ID: 22156481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current status and clinical course of hepatitis C virus in Korea].
    Kwon JH; Bae SH
    Korean J Gastroenterol; 2008 Jun; 51(6):360-7. PubMed ID: 18604137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of hepatocellular carcinoma in South Korea.
    Yoon SK; Chun HG
    Chin Clin Oncol; 2013 Dec; 2(4):39. PubMed ID: 25841918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver cancer in Korea.
    Han KH; Kim JK
    Hepatol Res; 2007 Sep; 37 Suppl 2():S106-9. PubMed ID: 17877469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.